Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Boosting Immune System Against Cancer by Resveratrol Publisher Pubmed



Chen L1 ; Musa AE2
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Pharmaceutical and Environmental Technology, Jilin Vocational College of Industry and Technology, Jilin, China
  2. 2. Department of Medical Physics, Tehran University of Medical Sciences, Tehran, Iran

Source: Phytotherapy Research Published:2021


Abstract

Modulation of the immune system is a critical part of anticancer therapies including immunotherapy, chemotherapy, and radiotherapy. The aim of immunomodulation in cancer therapy is boosting immune system cells including CD8+ T lymphocytes and natural killer (NK) cells, as well as suppression of immunosuppressive responses by macrophages and regulatory T cells (Tregs). Usually, using single or dual modality can induce immune system responses against cancer. However, immunosuppressive responses attenuate antitumor immunity following cancer therapy. Using some agents to boost immune system's function against cancer can increase therapeutic efficiency of anticancer therapy. Resveratrol, as a natural agent, has shown ability to modulate the immune system to potentiate antitumor immunity. Resveratrol has been shown to induce the release of anticancer cytokines such as IFN-γ and TNF-α and also inhibits the release of TGF-β. It also can stimulate the polarization of CD4+ T cells and macrophages toward anticancer cells and reduce infiltration and polarization of immunosuppressive cells. Furthermore, resveratrol can sensitize cancer cells to the released dead signals by anticancer immune cells. This review explains how resveratrol can boost the immune system against cancer via modulation of immune cell responses within tumor. © 2021 John Wiley & Sons Ltd.
Related Docs
View other Related Docs
1. Immunoregulation by Resveratrol; Implications for Normal Tissue Protection and Tumour Suppression, Clinical and Experimental Pharmacology and Physiology (2023)
2. Regulation of Cell Death Mechanisms by Melatonin: Implications in Cancer Therapy, Anti-Cancer Agents in Medicinal Chemistry (2022)
3. Resveratrol in Cancer Therapy: From Stimulation of Genomic Stability to Adjuvant Cancer Therapy: A Comprehensive Review, Current Topics in Medicinal Chemistry (2023)
4. The Interactions and Communications in Tumor Resistance to Radiotherapy: Therapy Perspectives, International Immunopharmacology (2020)
5. Nobiletin in Cancer Therapy; Mechanisms and Therapy Perspectives, Current Pharmaceutical Design (2023)
6. Tumor Immunology, Clinical Immunology (2022)
7. Applications of Resveratrol in the Treatment of Gastrointestinal Cancer, Biomedicine and Pharmacotherapy (2022)
8. Modulation of the Immune System by Melatonin; Implications for Cancer Therapy, International Immunopharmacology (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (8)
Elahe Motevaseli (4)
Other Related Docs
9. Damage-Associated Molecular Patterns in Tumor Radiotherapy, International Immunopharmacology (2020)
10. Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy, Current Cancer Drug Targets (2022)
11. Resveratrol As an Enhancer of Apoptosis in Cancer: A Mechanistic Review, Anti-Cancer Agents in Medicinal Chemistry (2021)
12. Resveratrol As an Adjuvant for Normal Tissues Protection and Tumor Sensitization, Current Cancer Drug Targets (2020)
13. Abscopal Effect in Radioimmunotherapy, International Immunopharmacology (2020)
14. Apigenin in Cancer Therapy: Prevention of Genomic Instability and Anticancer Mechanisms, Clinical and Experimental Pharmacology and Physiology (2023)
15. Cancer-Associated Immune Cells and Their Modulation by Melatonin, Immunopharmacology and Immunotoxicology (2023)
16. Understanding the Tumor Microenvironment for Effective Immunotherapy, Medicinal Research Reviews (2021)
17. Cancer Exosomes and Natural Killer Cells Dysfunction: Biological Roles, Clinical Significance and Implications for Immunotherapy, Molecular Cancer (2022)
18. Combining Anti-Checkpoint Immunotherapies and Cancer Vaccines As a Novel Strategy in Oncological Therapy: A Review, Human Immunology (2025)
19. Induction of Cancer Cell Death by Apigenin: A Review on Different Cell Death Pathways, Mini-Reviews in Medicinal Chemistry (2023)
20. The Potential Role of Immunotherapy in Wilms’ Tumor: Opportunities and Challenges, Current Pharmaceutical Design (2023)
21. Protection Against Ionizing Radiation-Induced Normal Tissue Damage by Resveratrol: A Systematic Review, Eurasian Journal of Medicine (2020)
22. Reduction–Oxidation (Redox) System in Radiation-Induced Normal Tissue Injury: Molecular Mechanisms and Implications in Radiation Therapeutics, Clinical and Translational Oncology (2018)
23. Exploring the Application of Immunotherapy Against Hiv Infection in the Setting of Malignancy: A Detailed Review Article, International Immunopharmacology (2022)
24. Resveratrol in Breast Cancer Treatment: From Cellular Effects to Molecular Mechanisms of Action, Cellular and Molecular Life Sciences (2022)
25. Apigenin As Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer, Frontiers in Chemistry (2020)
26. Melatonin Ameliorates Radiation-Induced Oxidative Stress at Targeted and Nontargeted Lung Tissue, Journal of Medical Physics (2017)
27. Metformin Protects the Rat Small Intestine Against Radiation Enteritis, Jundishapur Journal of Natural Pharmaceutical Products (2019)
28. Natural Killer Cells and Acute Myeloid Leukemia: Promises and Challenges, Cancer Immunology# Immunotherapy (2022)
29. Resveratrol Induces Apoptosis and Attenuates Proliferation of Mcf-7 Cells in Combination With Radiation and Hyperthermia, Current Molecular Medicine (2021)
30. Targeting of Inflammation for Radiation Protection and Mitigation, Current Molecular Pharmacology (2018)
31. An Update to Experimental and Clinical Aspects of Tumor-Associated Macrophages in Cancer Development: Hopes and Pitfalls, Clinical and Experimental Medicine (2024)
32. Radiation-Induced Non-Targeted Effect and Carcinogenesis; Implications in Clinical Radiotherapy, Journal of Biomedical Physics and Engineering (2018)
33. Concise Review: The Heterogenous Roles of Batf3 in Cancer Oncogenesis and Dendritic Cells and T Cells Differentiation and Function Considering the Importance of Batf3-Dependent Dendritic Cells, Immunogenetics (2024)
34. Radiation Protection and Mitigation by Natural Antioxidants and Flavonoids: Implications to Radiotherapy and Radiation Disasters, Current Molecular Pharmacology (2018)
35. Resistance Mechanisms to Programmed Cell Death Protein 1 and Programmed Death Ligand 1 Inhibitors, Expert Opinion on Biological Therapy (2021)
36. Testicular Niche Repair After Gonadotoxic Treatments: Current Knowledge and Future Directions, Biology of the Cell (2024)
37. Strategies for Enhancing Intratumoral Spread of Oncolytic Adenoviruses, Pharmacology and Therapeutics (2020)
38. Recent Progress in Cancer Immunotherapy: Overview of Current Status and Challenges, Pathology Research and Practice (2023)
39. Tumor-Promoting Myeloid Cells in the Pathogenesis of Human Oncoviruses: Potential Targets for Immunotherapy, Cancer Cell International (2022)
40. Resveratrol Effects on Molecular Pathways and Micrornas in Gastrointestinal Cancers, Current Medicinal Chemistry (2023)
41. Mechanisms of Inflammatory Responses to Radiation and Normal Tissues Toxicity: Clinical Implications, International Journal of Radiation Biology (2018)
42. A Systematic Review of the Therapeutic Effects of Resveratrol in Combination With 5-Fluorouracil During Colorectal Cancer Treatment: With a Special Focus on the Oxidant, Apoptotic, and Anti-Inflammatory Activities, Cancer Cell International (2022)
43. Immune Checkpoint Inhibitors in Cancer Therapy, Current Oncology (2022)
44. Therapeutic and Immunomodulatory Potentials of Mesenchymal Stromal/Stem Cells and Immune Checkpoints Related Molecules, Biomarker Research (2024)
45. Mechanisms of Radiation Bystander and Non-Targeted Effects: Implications to Radiation Carcinogenesis and Radiotherapy, Current Radiopharmaceuticals (2018)
46. Natural Killer Cell-Derived Exosomes for Cancer Immunotherapy: Innovative Therapeutics Art, Cancer Cell International (2023)
47. Current and Future Perspectives of Pd-1/Pdl-1 Blockade in Cancer Immunotherapy, Journal of Immunology Research (2021)
48. Cancer Immunology, Encyclopedia of Infection and Immunity (2022)
49. Cox-2 in Radiotherapy: A Potential Target for Radioprotection and Radiosensitization, Current Molecular Pharmacology (2018)